Chief Medical Officer

Chief Medical Officer – Immunology & Inflammation $125M Series AShape the clinical future of a biotech advancing therapies across multiple autoimmune diseases.Following a $125 million Series A, this Bay Area biotech is appointing a Chief Medical Officer as it prepares to enter the clinic in approximately 12 months.Joining at a pivotal stage, you will help translate the science into a clinical development strategy, with influence over indication selection, early trial design and the path to clinical proof of concept.The opportunityLead clinical and translational strategy across a pipeline targeting autoimmune diseases.Guide the transition from preclinical development into first-in-human studies.Shape patient selection, biomarker strategy and clinically meaningful endpoints.Build the clinical development team and help shape the company’s medical direction.Your backgroundYou’ll bring deep immunology and inflammation expertise, strong clinical development experience and the scientific judgement to evaluate opportunities across autoimmune indications. Experience advancing programmes into the clinic, alongside a hands-on approach to biotech leadership, would be particularly relevant.For a leader who wants to influence both what enters the clinic and how it is developed, this offers substantial scope at a formative stage.Interested? Contact me for a confidential discussion:spencer.knight@hartmannyoung.com